RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
58 hedge funds and large institutions have $20.4M invested in Rain Oncology Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+1
Holders Change %
+1.75%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
11
Closed
9
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$24K
Top Buyers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$1.53M |
| 2 |
DAM
Deltec Asset Management
New York
|
+$449K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$132K |
| 4 |
BlackRock
New York
|
+$90.4K |
| 5 |
Morgan Stanley
New York
|
+$90K |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$524K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$445K |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$280K |
| 4 |
Two Sigma Investments
New York
|
-$90.6K |
| 5 |
Two Sigma Advisers
New York
|
-$71.8K |
